Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies

E Maserati, A Minelli, B Pressato, R Valli… - Genes …, 2006 - Wiley Online Library
E Maserati, A Minelli, B Pressato, R Valli, B Crescenzi, M Stefanelli, G Menna, L Sainati…
Genes, chromosomes and cancer, 2006Wiley Online Library
An investigation of 14 patients with Shwachman syndrome (SS), using standard and
molecular cytogenetic methods and molecular genetic techniques, showed that (1) the i
(7)(q10) is not, or not always, an isochromosome but may arise from a more complex
mechanism, retaining part of the short arm;(2) the i (7)(q10) has no preferential parental
origin;(3) clonal chromosome changes, such as chromosome 7 anomalies and del
(20)(q11), may be present in the bone marrow (BM) for a long time without progressing to …
Abstract
An investigation of 14 patients with Shwachman syndrome (SS), using standard and molecular cytogenetic methods and molecular genetic techniques, showed that (1) the i(7)(q10) is not, or not always, an isochromosome but may arise from a more complex mechanism, retaining part of the short arm; (2) the i(7)(q10) has no preferential parental origin; (3) clonal chromosome changes, such as chromosome 7 anomalies and del(20)(q11), may be present in the bone marrow (BM) for a long time without progressing to myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML); (4) the del(20)(q11) involves the minimal region of deletion typical of MDS/AML; (5) the rate of chromosome breaks is not significantly higher than in controls, from which it is concluded that SS should not be considered a breakage syndrome; (6) a specific kind of karyotype instability is present in SS, with chromosome changes possibly found in single cells or small clones, often affecting chromosomes 7 and 20, in the BM. Hence, we have confirmed our previous hypothesis that the SS mutation itself implies a mutator effect that is responsible for MDS/AML through these specific chromosome anomalies. This conclusion supports the practice of including cytogenetic monitoring in the follow‐up of SS patients. © 2005 Wiley‐Liss, Inc.
Wiley Online Library